This session will focus on the history of toxic torts and how it has changed in recent years. The program will concentrate on traditional toxic torts, toxic torts that have spurred more recent litigation, and possible new toxic torts on the horizon. Our presenters will provide an overview of key litigation and developments and offer practical pointers on steps companies can take to help mitigate risk.

This is Part 10 of a eleven-part series. Part 1, The New EU Product Liability Directive: A Game-Changer for Biopharma, Medtech, and Digital Health Companies, is taking place on November 3, 2025, Part 2, Life Sciences Early-Stage Dealmaking: Trends and Diligence Strategy, is taking place on November 3, 2025, Part 3, Navigating the Evolving Frontier of Women’s Health and Fertility Treatments, is taking place on November 4, 2025, Part 4, From Pharma to Produce: California’s Evolving Tort Terrain, is taking place on November 4, Part 5, AI and Life Sciences: A Collision Course, is taking place on November 4, Part 6, Recent Developments in Vaccine Product Liability Litigation, is taking place on November 5, Part 7, A World Without Government Pricing Programs, is taking place on November 5, Part 8, AI and Ethics: Navigating and Challenging Improper Use in Legal Proceedings, is taking place on November 6, Part 9, Hot Topics in Fraud and Abuse for Medical Device Manufacturers, is taking place on November 6, Part 11, Something New Under the Sun? Novel Preemption Topics, is taking place on November 7.

CLE Information: This webinar is presumptively approved for 1.0 CLE credit in California, Connecticut, Illinois, New Jersey, New York, Pennsylvania, Texas and West Virginia. Applications for CLE credit will be filed in Colorado, Delaware, Florida, Georgia, Ohio, and Virginia. Attendees who are licensed in other jurisdictions will receive a uniform certificate of attendance but Reed Smith only provides credit for the states listed. Please allow 4-6 weeks after the program to receive a certificate of attendance.